Investor Presentaiton slide image

Investor Presentaiton

Reconciliation of GAAP to Adjusted Results 39 Reconciliation of Operating Profit to Adjusted Operating Profit (in thousands) Operating Profit Restructuring, Transaction and Other Charges (1) Focus 2023 Transformation, mainly real estate rescaling efforts Transaction costs Restructuring and integration charges Other Adjustments (2) Amortization of intangibles Other Adjusted Operating Profit $ September 29, 2023 Three Months Ended September 30, 2022 2023 Twelve Months Ended September 29, September 30, 2022 277,828 $ 308,540 1,075,237 $ 917,850 10,643 5,317 50,872 89,365 372 6,125 15,985 24,329 46,639 (24,544) 85,540 84,190 51,674 (4,162) 382,994 $ 51,713 203,906 198,602 980 347,151 $ 1,432,520 $ 1,314,336 (1) Includes estimated operating profit impacts relating to the separation activities around the CMS spin-off and from restructuring charges relating to the Company's investment in PA Consulting for the three months and year ended September 29, 2023, along with real estate impairments associated with the Company's Focus 2023 transformation program for the three months and years ended September 29, 2023 and September 30, 2022, and for the year ended September 30, 2022 related to the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves, approximately $27 million in third party recoveries recorded as receivables reducing SG&A, as well as operating profit impacts from charges associated with various transaction costs incurred with our acquisition and restructuring related activity associated with Company restructuring and integration programs. (2) Includes estimated operating profit impacts from amortization of intangible assets for the three months and years ended September 29, 2023 and September 30, 2022 and estimated operating profit impacts on certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment for the three months and year ended September 29, 2023. Jacobs 2023
View entire presentation